December 29, 2025 · Form 4 insider transaction
Umberger Traci S sold 10,500 shares of Kestra Medical Technologies, Ltd. at $26.69 per share, a transaction worth $280.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2025.; The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.51 to $26.96. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.; Includes 12,797 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.